News | Inno4Vac

Newsroom

Check on Inno4Vac latest news

Annual Meeting 2023 Inno4Vac: innovations to accelerate vaccine development and manufacture

October 2023 To advance the ambitious programme of Inno4Vac – which aims to harness the latest advances in immunology, disease modelling,...

Online platform on bio-manufacturing: workshop on integrating in silico models of unit operations

October 2023 Subtopic 4 ‘VAXinS’ of Inno4Vac is developing a modular one-stop computational platform for in silico modelling of vaccine...

Towards controlled human Clostridioides difficile colonization and infection

04 October 2023 The recent 13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (CLOSTPATH), in Banff,...

1st Inno4Vac newsletter is out!

We are pleased to share the 1st Inno4Vac newsletter where you will find a summary of the communication efforts by EVI over the last few...

The Inno4Vac Scientific and Ethics Advisory Committee has been appointed

August 2023 Inno4Vac announces the nomination of the independent Scientific and Ethics Advisory Committee (SEAC) of the Inno4Vac project....

A regulatory exchange on diversity and standardisation of 3D mucosal models for vaccine development

The 2nd Inno4Vac ST3 (MERMAID) Regulatory stakeholder meeting was held June 27-28 and hosted by the Paul-Ehrlich-Institut in Langen, GE.

Subtopic 1 VAXPRED meeting on 8-9 May 2023

16 May 2023 The subtopic1, VAXPRED, dedicated to build an open access and cloud-based platform to predict vaccine efficacy using...

Annual Meeting 2022 Inno4Vac: innovations to accelerate vaccine development and manufacture

16 November 2022 To advance the ambitious programme of Inno4Vac, which aims to harness the latest advances in immunology and disease...

First CHIMICHURRI workshop: developing a strategy for new challenge flu and RSV strain selection

14 December 2021 The subtopic 2, CHIMICHURRI, dedicated to the development of new and improved Control Human Infection Models (CHIM) for...

Inno4Vac kick-off meeting brings together over 150 partners

29 September 2021 The kick-off meeting of Inno4Vac, a project that targets faster vaccine development and manufacture, by harnessing the...

EVI to lead Inno4Vac, a new European public-private partnership to innovate vaccine development

The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 38.5 million to support Inno4Vac, an innovative...